GeneDx Holdings Corp. (WGS) Is A Bargain Stock You Should …

GeneDx Holdings Corp. (NASDAQ:WGS) has seen 2.11 million shares traded in the last trading session. The company, currently valued at £263.58M, closed the last trade at £0.33 per share which meant -1.51% during that session. The WGS stock price is -893.94% off its 52-week high price of £3.28 and 33.33% above the 52-week low of £0.22.

If we look at the company’s 10-day average daily trading volume, we find that it stood at 7.16 million shares traded. The 3-month trading volume is 4.29 million shares. The consensus among analysts is that GeneDx Holdings Corp. (WGS) is an Overweight stock at the moment, with a recommendation rating of 2.20.

0 analysts rate the stock as a Sell, while 0 rate it as Overweight.

2 out of 3 have rated it as a Hold, with 1 advising it as a Buy.

0 have rated the stock as Underweight. The expected earnings per share for the stock is -£0.16. From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it’s about to change everything we know about everything. With the global market for AI projected to grow from £137 billion in 2022 to over £1.81 trillion by 2030, there’s never been a better time to invest in this burgeoning industry. That’s why we’ve compiled a list of the Top 5 AI Stocks to Buy for 2023.

These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you. Get our free report, “Top 5 AI Stocks to Buy for 2023”. Sponsored

Sporting -1.51% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Friday, 03/24/23 when the WGS stock price touched £0.33 or saw a rise of 36.54%. Year-to-date, GeneDx Holdings Corp. shares have moved 23.24%, while the 5-day performance has seen it change -9.04%. Over the past 30 days, the shares of GeneDx Holdings Corp. (NASDAQ:WGS) have changed -30.53%.

Short interest in the company has seen 6.23 million shares shorted with days to cover at 2.6. Wall Street analysts have a consensus price target for the stock at £0.92, which means that the shares’ value could jump 64.13% from current levels. The projected low price target is £0.50 while the price target rests at a high of £1.25.

In that case, then, we find that the current price level is -278.79% off the targeted high while a plunge would see the stock gain -51.52% from current levels.

GeneDx Holdings Corp. (WGS) estimates and forecasts

Figures show that GeneDx Holdings Corp. shares have outperformed across the wider relevant industry. The company’s shares have lost -64.26% over the past 6 months, with this year growth rate of 88.96%, compared to 1.60% for the industry. Other than that, the company has, however, increased its growth outlook for the 2023 fiscal year revenue.

Growth estimates for the current quarter are 5.90% and 63.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 15.10%.

4 analysts offering their estimates for the company have set an average revenue estimate of £70.95 million for the current quarter.

4 have an estimated revenue figure of £48.26 million for the next quarter concluding in Mar 2023. Year-ago sales stood £57.8 million and £53.94 million respectively for this quarter and the next, and analysts expect sales will grow by 22.70% for the current quarter and -10.50% for the next.

WGS Dividends

GeneDx Holdings Corp. is expected to release its next earnings report between May 10 and May 15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

GeneDx Holdings Corp. (NASDAQ:WGS)’s Major holders

Insiders own 28.53% of the company shares, while shares held by institutions stand at 43.97% with a share float percentage of 61.52%.

Investors are also buoyed by the number of investors in a company, with GeneDx Holdings Corp. having a total of 130 institutions that hold shares in the company. The top two institutional holders are Blackstone Inc with over 27.66 million shares worth more than £24.27 million. As of Sep 29, 2022, Blackstone Inc held 7.25% of shares outstanding.

The other major institutional holder is Deerfield Management Company, L.P. (Series C), with the holding of over 16.97 million shares as of Sep 29, 2022. The firm’s total holdings are worth over £14.89 million and represent 4.45% of shares outstanding. Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund.

As of Sep 29, 2022, the former fund manager holds about 1.11% shares in the company for having 4.25 million shares of worth £3.73 million while later fund manager owns 3.71 million shares of worth £3.25 million as of Sep 29, 2022, which makes it owner of about 0.97% of company’s outstanding stock.